scispace - formally typeset
M

Mako Narisawa-Saito

Researcher at National Cancer Research Institute

Publications -  22
Citations -  1869

Mako Narisawa-Saito is an academic researcher from National Cancer Research Institute. The author has contributed to research in topics: Carcinogenesis & HRAS. The author has an hindex of 18, co-authored 22 publications receiving 1675 citations.

Papers
More filters
Journal ArticleDOI

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins.

TL;DR: The mechanisms of HPV16 E6‐ and E7‐induced multistep carcinogenesis and recently identified functions of these onco‐proteins are reviewed.
Journal ArticleDOI

Regulation of Notch1 gene expression by p53 in epithelial cells.

TL;DR: A novel link between p53 and Notch1 in keratinocyte differentiation upon genotoxic stress is demonstrated and a novel tumor suppressor mechanism of p53 in the development of squamous cell carcinomas, including HPV-induced tumors is suggested.
Journal ArticleDOI

NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer

TL;DR: Recurrent NRF2 mutation confers malignant potential and resistance to therapy in advanced ESC, resulting in a poorer outcome, and efficient inhibition of aberrantNRF2 activation could be a promising approach in combination with CRT.
Journal ArticleDOI

Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability.

TL;DR: Data from several different systems all strongly indicate that unregulated Cdt1 overexpression at pathophysiological levels can induce chromosomal damage other than rereplication in non-transformed cells, and it is found that deregulated Cdt 1 induces chromosomal instability in normal human cells.
Journal ArticleDOI

Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.

TL;DR: Results indicate that inactivation of p53 and activation of the Ras pathway play critical roles in ovarian carcinogenesis in co-operation with the Akt or c-myc pathways.